You know you have some issues when your skin turns a bright orange.
And it turns out you don’t need to spend a fortune to get rid of them.
A new study published in the American Journal of Clinical Nutrition found that an oil called body lavender (a.k.a.
BLE) has a protective effect against melanoma and other skin cancers.
It’s actually been shown to lower the risk by more than a factor of two.
Now, there’s some controversy over the efficacy of this oil, and a lot of skepticism surrounding its efficacy in people with melanoma.
It was even questioned in 2012 when it was discovered that a popular anti-aging and anti-inflammatory drug, ursodeoxycholic acid (uSAD), has the potential to raise the risk for melanoma in people who already have it.
However, the research done on this oil found that it did have a strong protective effect.
“The data indicate that this oil has a significant and protective effect on the progression of melanoma,” Dr. Shashi Rao, the lead author of the study and an associate professor of medicine at Emory University, told Business Insider.
Rao and his team were interested in this oil because it could potentially be a safe alternative to standard anti-skin therapies.
That means that it could help people with other skin diseases, including skin cancer.
It could also help with the skin cancer in a more aggressive form.
Dr. Rakesh Chandra, an associate director of the Emory Skin Cancer Center, agreed.
“This is an amazing finding that we’ve been waiting for for years,” Chandra told Business Insiders.
“It’s a huge leap forward in understanding the biology of skin cancer and the potential of BLE for preventing the disease.”
Dr. Rao, Chandra, and their team used clinical trials to examine the efficacy and safety of BLES in melanoma patients.
The studies were conducted in a clinical trial in patients with advanced melanoma, where they were given BLE to treat the disease.
The patients who received BLE had an increased risk of dying from the disease, but they also had a significant reduction in the progression.
Rajendra Bhaskar, one of the lead researchers of the studies, told the Huffington Post that the researchers were surprised by the results.
“We didn’t expect to see an increase in survival,” he said.
“I don’t know what the rationale is.
It just doesn’t make sense.
This is just so exciting.”
It was also interesting to see that the patients who had received BLES had significantly reduced their risk of getting melanoma compared to those who had not received Bles.
The researchers noted that BLE appears to have some anti-cancer properties, but there’s not enough data yet to determine how much of that effect was due to BLE.
Dr Chandra said that there are still some unanswered questions about the safety of this product.
“There is a lot that we don’t yet know about BLE,” he told BusinessInsiders.
For instance, BLE has a high toxicity and may be more dangerous for people with more advanced cancers.”BLE has been shown in studies to be toxic to humans,” Rao said.
It has been linked to skin cancer development in animal models, but the safety for humans is not known.
Dr. Chandra noted that there is no evidence to suggest that BLES is a carcinogen.
“I don’ know if BLE is a safe agent, and I’m not going to prescribe it for myself.
It is not for everyone,” he added.